Ayala Pharmaceuticals Année d'introduction en bourse
Quel est le Année d'introduction en bourse de Ayala Pharmaceuticals?
Le Année d'introduction en bourse de Ayala Pharmaceuticals Inc. est 2005
Quelle est la définition de Année d'introduction en bourse?
Le premier appel public à l'épargne est un type d'offre publique dans lequel les actions d'une entreprise sont généralement vendues à des investisseurs institutionnels qui, pour leur part, vendent au grand public, pour la première fois, sur une bourse de valeurs.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Année d'introduction en bourse des entreprises dans Health Care secteur sur NASDAQ par rapport à Ayala Pharmaceuticals
Que fait Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Entreprises avec année d'introduction en bourse similaire à Ayala Pharmaceuticals
- Rurelec PLC a Année d'introduction en bourse de 2004
- Kona Bay Technologies a Année d'introduction en bourse de 2004
- FE Investments a Année d'introduction en bourse de 2004
- JBF Industries a Année d'introduction en bourse de 2004
- Indiabulls Ventures a Année d'introduction en bourse de 2004
- Alexion Pharmaceuticals a Année d'introduction en bourse de 2004
- Ayala Pharmaceuticals a Année d'introduction en bourse de 2005
- Compass Diversified a Année d'introduction en bourse de 2006
- Green Plains Inc a Année d'introduction en bourse de 2006
- Catalyst Pharmaceuticals Inc a Année d'introduction en bourse de 2006
- Greatland Gold Plc a Année d'introduction en bourse de 2006
- Capital Environment a Année d'introduction en bourse de 2006
- Athena Resources a Année d'introduction en bourse de 2006